https://www.passagebio.com/generated by Q4Thu, 09 Apr 2026 17:55:33 -0400Copyright Q4 Inc. All rights reserved.83b4eca8-4214-4269-80ec-a9cf98ff9cd5https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2026/Passage-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Recent-Business-Highlights/default.aspxTue, 03 Mar 2026 07:00:00 -050042fb8351-a474-4386-91ab-bc6c603a26dchttps://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2026/Passage-Bio-to-Participate-in-Upcoming-Investor-Conferences/default.aspxThu, 19 Feb 2026 07:00:00 -05009ce03c72-2fed-4479-975b-f8c5b193ec74https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Recent-Business-Highlights/default.aspxMon, 10 Nov 2025 16:15:00 -0500d916cb55-71df-4060-bcfe-dee4d563ca37https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-to-Present-at-Guggenheim-Securities-2nd-Annual-Healthcare-Innovation-Conference/default.aspxWed, 05 Nov 2025 07:00:00 -05002b5786f8-f318-4528-acc7-df83871c56achttps://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-to-Participate-in-Chardans-9th-Annual-Genetic-Medicines-Conference/default.aspxTue, 14 Oct 2025 07:00:00 -040000024894-dc59-48c7-9aa3-c428003ca3b5https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-to-Participate-in-H-C--Wainwright-27th-Annual-Global-Investment-Conference/default.aspxThu, 28 Aug 2025 07:00:00 -04000b5913f1-34fa-4e3f-83fe-242ac240578fhttps://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Recent-Business-Highlights/default.aspxTue, 12 Aug 2025 07:00:00 -04008ca02b7f-5807-4d10-bf14-f27e9455c2b2https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-Announces-1-for-20-Reverse-Stock-Split/default.aspxThu, 10 Jul 2025 07:00:00 -0400db05d20a-212d-459b-b3e6-1ab1c8534e74https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-Reports-Updated-Interim-Data-from-upliFT-D-Study-and-Provides-Program-Update/default.aspxMon, 23 Jun 2025 07:00:00 -040044d2d99b-cbaa-4969-a97c-ec3616f7df6bhttps://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2025/Passage-Bio-Reports-First-Quarter-2025-Financial-Results-and-Provides-Recent-Business-Highlights/default.aspxTue, 13 May 2025 07:00:00 -0400